These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33537787)

  • 1. Improving Fecal Immunochemical Testing Rates for Colon Cancer Screening in the Outpatient Setting.
    Hussain W; Aurand W; Onuorah N; Krstevski G; Markert R; Springer K; Agrawal S
    South Med J; 2021 Feb; 114(2):77-80. PubMed ID: 33537787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
    Nielson CM; Vollmer WM; Petrik AF; Keast EM; Green BB; Coronado GD
    J Gen Intern Med; 2019 Jun; 34(6):978-985. PubMed ID: 30684199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Fecal Immunochemical Test Return Rates: A Colorectal Cancer Screening Quality Improvement Project in a Multisite Federally Qualified Health Center.
    Zoellner JM; Porter KJ; Thatcher E; Allanson D; Brauns M
    Health Promot Pract; 2023 Jul; 24(4):740-754. PubMed ID: 35382617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.
    Coronado GD; Rivelli JS; Fuoco MJ; Vollmer WM; Petrik AF; Keast E; Barker S; Topalanchik E; Jimenez R
    J Gen Intern Med; 2018 Jan; 33(1):72-78. PubMed ID: 29019046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
    Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
    J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Lam TYT; Wu PI; Tang RSY; Luk AKC; Ng S; Sung JJY
    Cancer; 2021 Mar; 127(6):914-921. PubMed ID: 33216357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.
    Davis MM; Coury J; Larson JH; Gunn R; Towey EG; Ketelhut A; Patzel M; Ramsey K; Coronado GD
    J Rural Health; 2023 Jan; 39(1):279-290. PubMed ID: 35703582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of reminder strategies on cancer screening adherence: a randomised controlled trial.
    Wong MC; Ching JY; Huang J; Wong JC; Lam TY; Chan VC; Ng SK; Hui Z; Luk AK; Wu JC; Chan FK
    Br J Gen Pract; 2018 Sep; 68(674):e604-e611. PubMed ID: 30104327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
    Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up approaches to a health literacy intervention to increase colorectal cancer screening in rural community clinics: A randomized controlled trial.
    Arnold CL; Rademaker AW; Morris JD; Ferguson LA; Wiltz G; Davis TC
    Cancer; 2019 Oct; 125(20):3615-3622. PubMed ID: 31355924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial to improve colon cancer screening in rural family medicine: an Iowa Research Network (IRENE) study.
    Levy BT; Xu Y; Daly JM; Ely JW
    J Am Board Fam Med; 2013; 26(5):486-97. PubMed ID: 24004700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
    Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
    BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
    Green BB; West II; Baldwin LM; Schwartz MR; Coury J; Coronado GD
    J Community Health; 2020 Oct; 45(5):916-921. PubMed ID: 32219712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature.
    Doubeni CA; Jensen CD; Fedewa SA; Quinn VP; Zauber AG; Schottinger JE; Corley DA; Levin TR
    J Am Board Fam Med; 2016 Nov; 29(6):672-681. PubMed ID: 28076249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.